<?xml version="1.0" encoding="UTF-8"?>
<svg height="870.031005859375" width="672.0029907226562" xmlns="http://www.w3.org/2000/svg">
 <g style="fill:none;">
  <path d=" M 0.05999799817800522 826.072021484375 L 22.619997024536133 826.072021484375 L 22.619997024536133 826.35546875 L 0.05999799817800522 826.35546875 Z " style="fill:none;stroke:#000000;stroke-width:1.0;"/>
  <path d=" M 33.67599868774414 837.4110107421875 L 33.959449768066406 837.4110107421875 L 33.959449768066406 860.031005859375 L 33.67599868774414 860.031005859375 Z " style="fill:none;stroke:#000000;stroke-width:1.0;"/>
  <path d=" M 627.9869995117188 837.4110107421875 L 628.2703857421875 837.4110107421875 L 628.2703857421875 860.031005859375 L 627.9869995117188 860.031005859375 Z " style="fill:none;stroke:#000000;stroke-width:1.0;"/>
  <path d=" M 639.3259887695312 826.072021484375 L 662.0029907226562 826.072021484375 L 662.0029907226562 826.35546875 L 639.3259887695312 826.35546875 Z " style="fill:none;stroke:#000000;stroke-width:1.0;"/>
  <path d=" M 639.3259887695312 33.731998443603516 L 662.0029907226562 33.731998443603516 L 662.0029907226562 34.015480041503906 L 639.3259887695312 34.015480041503906 Z " style="fill:none;stroke:#000000;stroke-width:1.0;"/>
  <path d=" M 627.9869995117188 0.0 L 628.2703857421875 0.0 L 628.2703857421875 22.677000045776367 L 627.9869995117188 22.677000045776367 Z " style="fill:none;stroke:#000000;stroke-width:1.0;"/>
  <path d=" M 33.67599868774414 0.0 L 33.959449768066406 0.0 L 33.959449768066406 22.677000045776367 L 33.67599868774414 22.677000045776367 Z " style="fill:none;stroke:#000000;stroke-width:1.0;"/>
  <path d=" M 0.05999799817800522 33.731998443603516 L 22.619997024536133 33.731998443603516 L 22.619997024536133 34.015480041503906 L 0.05999799817800522 34.015480041503906 Z " style="fill:none;stroke:#000000;stroke-width:1.0;"/>
  <text x="72.057,74.463,78.587,82.711,85.117,88.44,92.176,94.193,98.318,102.054,106.178,109.914,111.931,114.234,119.598,121.615,123.984,130.208,133.944,136.821,139.697,141.715,143.732,145.749,148.077,153.442,159.666,161.683,164.063,171.535,174.8,178.924,182.66,186.785,190.521,192.927,198.291,202.027,205.292,209.417,212.682,215.559,219.683,223.808,226.193,230.318,232.335,234.64,237.905,240.311,242.633,246.369,248.387,250.404,252.724,257.237,260.502,264.627,266.644,270.38,274.505,276.874,280.139,282.156,285.421,289.157,292.893,295.299,297.316,301.441,305.565,308.442,310.773,312.791" y="37.76400000000001" svg_rhmargin="316.915" style="fill:#171615;font-family:NEAGBA+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">[24] Singhal R, Harrill AH, Menguy-Vacheron F, et al. Benign elevations in</text>
  <text x="88.441,91.318,94.583,97.459,101.584,107.726,110.776,114.512,120.654,122.671,126.796,130.92,133.326,136.286,140.022,144.146,147.023,149.429,152.694,155.571,159.306,162.183,165.448,168.32500000000002,171.376,175.112,179.236,183.361,186.455,190.58,192.597,196.721,202.863,206.599,209.476,213.6,216.865,219.742,222.619,225.684,229.808,232.214,235.321,239.445,242.71,246.835,250.571,252.977,257.101,259.507,263.631,267.756,269.773,273.038,275.056,277.462,281.198,284.299,286.317,290.442,293.483,297.608,300.873,304.609,306.626,309.032,313.157" y="46.721000000000004" svg_rhmargin="316.893" style="fill:#171615;font-family:NEAGBA+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">serum aminotransferases and biomarkers of hepatotoxicity in healthy</text>
  <text x="88.441,92.177,96.301,98.319,102.443,106.567,108.973,112.239,115.504,118.38,121.25699999999999,126.762,129.168,132.045,135.31,139.046,141.452,144.717,148.842,154.37,160.123,162.14,164.546,168.671,174.211,177.476,181.601,185.725,187.743,191.008,193.884,196.29,200.026,202.903,206.639,212.872,214.89,219.014,222.279,224.296,229.766,234.279,241.751,247.116,252.612,256.736,260.861,264.597,267.473,273.615,277.351,280.616,284.811,286.828,292.295,297.196,301.321,305.445,307.462,310.728,314.852" y="55.678" svg_rhmargin="316.869" style="fill:#171615;font-family:NEAGBA+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">volunteers treated with cholestyramine. BMC Pharmacol Toxicol</text>
  <text x="88.441,92.566,96.691,100.816,104.942,106.96,111.085,115.21,117.228,121.353,125.479" y="64.63599999999997" svg_rhmargin="127.496" style="fill:#171615;font-family:NEAGBA+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">2014;15:42.</text>
  <text x="72.057,74.463,78.587,82.711,85.117,88.44,94.193,96.211,100.335,104.071,106.184,111.937,113.954,116.104,121.858,123.875,128.0,131.736,133.905,136.781,138.798,140.934,147.076,149.093,153.218,156.95399999999998,159.131,162.007,164.024,166.16,169.425,171.83100000000002,173.983,177.719,179.737,181.754,183.904,189.268,191.286,194.162,197.428,201.552,203.569,207.305,209.711,211.729,215.853,219.589,221.771,227.914,229.931,233.196,236.073,240.198,245.562,251.704,257.069,259.475,263.599,267.724,271.849,274.038,277.774,280.651,282.825,286.561,288.664,292.788,296.913,299.319,302.584,306.708,309.114,311.132,314.868" y="73.59299999999996" svg_rhmargin="316.885" style="fill:#171615;font-family:NEAGBA+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">[25] Ding X, Ding J, Ning J, et al. Circulating microRNA-122 as a potential</text>
  <text x="88.441,92.565,94.583,98.707,104.849,108.585,111.461,115.586,118.851,121.728,124.267,126.673,130.798,133.675,136.172,138.19,140.207,143.943,147.208,150.085,152.612,154.629,158.753,160.771,164.895,167.772,171.508,173.525,176.081,183.552,187.677,189.694,192.18,199.652,202.917,207.042,209.527,214.893,218.158,222.283,224.834,228.959,233.083,237.207,241.332,243.349,247.474,249.491,253.615,257.74,261.864" y="82.54999999999995" svg_rhmargin="265.988" style="fill:#171615;font-family:NEAGBA+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">biomarker for liver injury. Mol Med Rep 2012;5:1428</text>
  <text x="266.059" y="82.54999999999995" svg_rhmargin="269.795" style="fill:#171615;font-family:NEAGKI+AdvOTbc475f09+20;font-size:7.47px;font-style:NORMAL;font-weight:normal;">–</text>
  <text x="269.801,273.926,278.051" y="82.54999999999995" svg_rhmargin="280.068" style="fill:#171615;font-family:NEAGBA+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">32.</text>
  <text x="72.057,74.463,78.588,82.712,85.11800000000001,88.441,93.806,95.823,97.84,101.106,104.841,108.107,112.231,114.637,118.761,122.497,125.374,127.78,129.71,135.075,140.828,145.341,147.358,149.211,153.723,156.989,159.865,163.13,167.255,171.379,174.256,176.137,181.502,183.519,185.378,189.502,193.627,196.033,198.438,201.704,204.58100000000002,206.466,211.831,219.303,222.179,224.196,226.08,229.346,231.752,233.62,237.356,239.373,241.39,243.257,250.729,252.746,256.012,258.888,263.013,268.377,274.519,279.884,282.29,286.414,290.539,294.664,296.544,299.809,303.545,307.67,309.526,313.651" y="91.56399999999996" svg_rhmargin="316.916" style="fill:#171615;font-family:NEAGBA+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">[26] Vliegenthart ADB, Berends C, Potter CMJ, et al. MicroRNA-122 can be</text>
  <text x="88.442,94.583,97.849,101.585,104.461,108.586,111.462,114.727,118.852,121.944,123.962,128.087,131.185,134.45,138.186,142.31,144.328,146.345,148.362,152.098,154.975,158.71099999999998,161.854,165.978,167.995,172.12,176.244,180.369,183.452,189.206,193.33,195.347,198.613,202.738,205.845,208.25,211.986,215.252,217.269,219.286,221.304,223.71,227.445,229.851,233.117,235.994,239.12,243.245,247.369,249.386,253.576,255.982,258.388,262.512,264.918,267.324,270.589,274.325,277.202,280.467,283.564,285.97,289.235,292.112,294.518,296.535,300.659,304.395,307.543,309.949,314.073" y="100.52099999999996" svg_rhmargin="316.95" style="fill:#171615;font-family:NEAGBA+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">measured in capillary blood which facilitates point-of-care testing for</text>
  <text x="88.442,92.566,95.443,99.567,103.303,105.709,107.726,111.851,115.975,120.1,123.365,126.63,130.755,133.282,135.3,137.317,141.053,144.318,147.19500000000002,149.722,151.739,155.863,157.881,162.005,164.882,168.618,170.635,173.191,177.703,180.58,183.055,185.93200000000002,188.44,193.806,195.823,197.841,201.966,204.485,208.609,212.734,216.469,219.346,225.488,229.224,232.489,236.684,238.701,241.162,245.287,249.411,253.536,257.66,259.677,263.802,267.926,270.016,274.14,278.265,282.389" y="109.47799999999995" svg_rhmargin="286.513" style="fill:#171615;font-family:NEAGBA+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">drug-induced liver injury. Br J Clin Pharmacol 2017;83:2027</text>
  <text x="286.526" y="109.47799999999995" svg_rhmargin="290.262" style="fill:#171615;font-family:NEAGKI+AdvOTbc475f09+20;font-size:7.47px;font-style:NORMAL;font-weight:normal;">–</text>
  <text x="290.268,294.393,298.518" y="109.47799999999995" svg_rhmargin="300.535" style="fill:#171615;font-family:NEAGBA+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">33.</text>
  <text x="72.058,74.464,78.589,82.713,85.119,88.442,93.806,97.542,103.684,107.42,111.544,114.421,118.15700000000001,120.924,126.289,128.306,131.072,135.974,139.71,142.116,144.993,149.117,155.335,157.352,160.098,166.24,168.257,171.039,175.94,179.676,183.8,187.536,191.272,193.289,196.039,199.774,201.791,204.599,207.864,210.27,212.989,216.725,218.742,220.759,223.533,227.269,230.534,233.411,237.535,243.677,246.493,252.635,254.653,257.918,260.794,264.919,270.284,276.425,281.79,284.588,288.713,291.589" y="118.43600000000004" svg_rhmargin="295.713" style="fill:#171615;font-family:NEAGBA+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">[27] Yamaura Y, Tatsumi N, Takagi S, et al. Serum microRNA pro</text>
  <text x="295.767" y="118.43600000000004" svg_rhmargin="299.891" style="fill:#171615;font-family:NEAGBC+AdvOTbc475f09+fb;font-size:7.47px;font-style:NORMAL;font-weight:normal;">ﬁ</text>
  <text x="299.906,301.923,305.188,308.065,310.79,312.807" y="118.43600000000004" svg_rhmargin="316.931" style="fill:#171615;font-family:NEAGBA+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">les in</text>
  <text x="88.442,92.567,96.303,98.709,100.726,103.991,108.116,110.522,113.399,116.503,122.257,124.274,126.68,130.805,133.851,137.116,141.24,144.117,148.241,152.366,154.383,157.648,160.721,164.845,168.11,172.235,175.971,178.377,180.394,182.8,184.817,187.69400000000002,190.822,195.335,197.352,200.403,203.668,207.792,210.669,214.794,218.918,220.935,224.2,227.273,231.397,234.663,238.787,242.523,244.929,246.946,249.352,251.369,254.246,257.375,262.739,264.756,267.805,271.93,274.806,276.824,282.965,286.701,289.578,293.31399999999996,296.377,300.501,302.518,304.536,306.553,310.289,313.166" y="127.39300000000003" svg_rhmargin="316.902" style="fill:#171615;font-family:NEAGBA+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">patients with chronic hepatitis B, chronic hepatitis C, primary biliary</text>
  <text x="88.442,91.708,93.725,96.602,99.478,103.603,107.727,110.604,112.621,115.498,117.515,120.357,124.093,128.218,130.624,134.748,136.765,142.907,149.049,153.174,157.298,160.563,163.384,167.509,170.774,174.899,178.634,181.04,183.058,185.55,187.567,190.444,192.46099999999998,195.243,199.368,203.492,207.617,211.353,213.37,216.635,220.76,224.884,229.086,231.104,233.121,236.386,239.177,242.054,244.46,247.725,251.461,253.867,257.991,262.115,265.381,269.505,273.241,275.647,277.664,280.07,282.087,284.964,286.981,289.856,293.98,296.857,299.663,303.788,306.664,310.789,314.525" y="136.35000000000002" svg_rhmargin="316.931" style="fill:#171615;font-family:NEAGBA+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">cirrhosis, autoimmune hepatitis, nonalcoholic steatohepatitis, or drug-</text>
  <text x="88.442,90.46,94.584,98.709,102.833,106.098,109.363,113.488,115.993,118.011,120.028,123.764,127.029,129.906,132.433,134.45,138.574,140.592,144.716,147.593,151.329,153.346,155.902,161.266,163.284,165.301,169.426,171.945,176.458,178.475,182.6,185.865,189.989,193.255,199.397,201.933,206.057,210.182,214.306,218.431" y="145.36400000000003" svg_rhmargin="220.448" style="fill:#171615;font-family:NEAGBA+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">induced liver injury. Clin Biochem 2017.</text>
  <text x="72.058,74.464,78.589,82.713,85.119,88.442,93.806,97.931,101.667,103.684,107.42,110.297,114.033,118.157,120.17399999999999,124.949,131.091,135.215,137.232,142.012,148.237,151.973,155.709,159.445,162.321,166.446,168.463,173.248,177.372,183.597,185.614,190.368,194.881,199.006,203.13,207.254,211.379,215.115,217.991,222.116,225.852,230.617,236.841,241.354,243.371,248.134,251.399,253.805,258.566,262.301,264.319,266.336,271.094,276.459,281.824,287.577,292.353,297.718,299.735,301.753,305.877,307.894,311.16,314.896" y="154.32100000000003" svg_rhmargin="316.913" style="fill:#171615;font-family:NEAGBA+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">[28] Chalasani NP, Hayashi PH, Bonkovsky HL, et al. ACG Clinical</text>
  <text x="88.442,94.196,98.32,100.337,104.462,107.727,109.744,111.762,115.886,119.151,121.16799999999999,123.192,125.598,129.723,132.988,134.983,139.108,141.125,144.861,148.597,152.722,156.922,159.799,161.816,164.693,166.673,170.409,174.533,178.658,180.675,186.817,190.553,194.677,198.413,202.149,205.414,211.556,214.821,218.946,221.352,223.417,227.543,229.949,231.922,233.939,238.064,240.081,244.205,247.082,250.818,254.942,258.208,261.084,264.82,267.226,269.335,272.59999999999997,274.551,278.677,281.553,285.678,289.414,291.819,293.837,297.961,302.159,306.283,309.549,312.814" y="163.27800000000002" svg_rhmargin="316.938" style="fill:#171615;font-family:NEAGBA+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">Guideline: the diagnosis and management of idiosyncratic drug-induced</text>
  <text x="88.442,90.46,92.477,96.213,99.478,102.35499999999999,104.882,106.899,111.024,113.041,117.165,120.042,123.778,125.795,128.294,133.659,139.801,142.353,145.23000000000002,147.682,153.436,157.172,160.048,162.454,165.331,169.455,172.721,176.934,179.34,182.605,185.482,189.606,191.623,194.111,198.236,202.36,206.485,210.609,212.627,216.751,220.876,225.0,227.104,231.228,235.353" y="172.236" svg_rhmargin="239.477" style="fill:#171615;font-family:NEAGBA+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">liver injury. Am J Gastroenterol 2014;109:950</text>
  <text x="239.471" y="172.236" svg_rhmargin="243.207" style="fill:#171615;font-family:NEAGKI+AdvOTbc475f09+20;font-size:7.47px;font-style:NORMAL;font-weight:normal;">–</text>
  <text x="243.213,247.338,251.464,253.481,255.97,260.094,264.219,266.238,269.503,272.014,276.139,280.264,284.39" y="172.236" svg_rhmargin="286.407" style="fill:#171615;font-family:NEAGBA+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">66. quiz 967.</text>
  <text x="72.058,74.464,78.589,82.713,85.119,88.442,92.566,96.302,100.426,104.551,108.287,112.081,119.553,123.289,125.306,129.144,132.88,136.616,140.741,144.006,148.13,151.395,154.66,158.509,165.981,167.998,171.831,177.196,181.321,185.445,187.851,191.587,194.464,198.305,203.67,206.546,208.563,212.364,215.629,218.035,221.831,225.567,227.584,229.601,233.453,239.206,242.083,246.207,249.943,252.349,254.366,258.491,262.615,266.74,270.005,273.361,277.486,281.298,284.564,288.688,292.812,294.83,298.095,300.972,303.378,307.113,309.99,312.008,314.884" y="181.19299999999998" svg_rhmargin="316.901" style="fill:#171615;font-family:NEAGBA+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">[29] Padda MS, Sanchez M, Akhtar AJ, et al. Drug-induced cholestasis.</text>
  <text x="88.442,94.667,97.933,102.058,105.795,108.202,112.327,114.344,116.848,120.972,125.098,129.223,133.348,135.366,139.491,143.616,145.706,149.831,153.957,158.082" y="190.14999999999998" svg_rhmargin="162.206" style="fill:#171615;font-family:NEAGBA+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">Hepatol 2011;53:1377</text>
  <text x="162.199" y="190.14999999999998" svg_rhmargin="165.935" style="fill:#171615;font-family:NEAGKI+AdvOTbc475f09+20;font-size:7.47px;font-style:NORMAL;font-weight:normal;">–</text>
  <text x="165.941,170.067,174.192" y="190.14999999999998" svg_rhmargin="176.209" style="fill:#171615;font-family:NEAGBA+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">87.</text>
  <text x="72.058,74.464,78.589,82.713,85.119,88.442,93.806,97.072,100.807,104.073,107.809,109.756,115.121,117.13799999999999,119.11,123.623,125.641,129.765,132.642,136.766,139.643,142.52,146.717,150.842,152.784,157.297,161.033,163.04999999999998,165.029,170.782,173.659,177.783,181.519,183.925,185.943,190.067,194.192,198.316,201.581,204.938,209.063,211.004,213.021,215.039,218.775,222.04,224.917,226.877,228.894,233.019,235.036,239.161,242.037,245.773,247.79,249.779,255.921,260.045,262.922,267.046,269.063,273.188,275.288,277.694,281.43,283.447,285.379,291.521,295.645,298.522,300.928,304.664,306.681,308.791,311.197,314.933" y="199.10699999999997" svg_rhmargin="316.95" style="fill:#171615;font-family:NEAGBA+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">[30] Regev A, Bjornsson ES. Drug-induced liver injury: morbidity, mortality,</text>
  <text x="88.442,92.179,96.304,100.429,102.9,109.124" y="208.12099999999998" svg_rhmargin="112.86" style="fill:#171615;font-family:NEAGBA+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">and Hy</text>
  <text x="112.877" y="208.12099999999998" svg_rhmargin="114.894" style="fill:#171615;font-family:NEAGKI+AdvOTbc475f09+20;font-size:7.47px;font-style:NORMAL;font-weight:normal;">’</text>
  <text x="114.918,117.795,120.304,122.321,126.057,131.81,133.827,136.346,142.1,145.836,148.713,151.119,153.995,158.12,161.385,165.51,167.915,171.181,174.057,178.182,180.19899999999998,182.775,186.899,191.023,195.148,199.272,201.29,205.414,209.539,213.663,215.68,219.805" y="208.12099999999998" svg_rhmargin="223.929" style="fill:#171615;font-family:NEAGBA+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">s law. Gastroenterol 2014;147:20</text>
  <text x="223.994" y="208.12099999999998" svg_rhmargin="227.73" style="fill:#171615;font-family:NEAGKI+AdvOTbc475f09+20;font-size:7.47px;font-style:NORMAL;font-weight:normal;">–</text>
  <text x="227.736,231.861" y="208.12099999999998" svg_rhmargin="233.878" style="fill:#171615;font-family:NEAGBA+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">4.</text>
  <text x="72.058,74.464,78.589,82.713,85.119,88.442,93.806,97.931,101.667,103.684,107.42,110.297,114.033,118.157,120.17399999999999,121.774,127.916,129.933,131.525,136.038,140.162,144.287,148.411,152.536,156.271,159.148,163.273,167.009,168.655,174.879,179.392,181.409,182.997,187.122,191.246,195.371,197.777,201.512,205.637,209.373,211.002,216.366,218.383,219.959,223.224,225.63,227.215,230.951,232.969,234.986,236.569,240.694,243.959,247.695,250.101,254.225,257.102,260.367,263.244,264.857,268.593,272.717,276.842,278.462,282.587,286.711,289.117,292.382,296.507,302.648,305.914,308.791,310.434,314.558" y="217.07799999999997" svg_rhmargin="316.964" style="fill:#171615;font-family:NEAGBA+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">[31] Chalasani N, Bonkovsky HL, Fontana R, et al. Features and outcomes of</text>
  <text x="88.442,92.567,96.691,100.816,102.275,106.399,110.135,112.541,114.559,117.824,121.948,124.354,127.231,128.691,134.445,136.462,138.868,142.993,144.451,148.575,151.452,155.577,159.312,161.798,163.815,167.939,172.064,176.188,179.453,182.719,186.844,188.271,190.288,192.306,196.042,199.382,202.25900000000001,203.691,205.709,209.833,211.85,215.975,218.851,222.587,224.60399999999998,226.083,228.489,232.613,235.878,237.364,243.118,245.524,250.037,252.442,258.584,260.04,264.164,267.041,271.165,274.042,278.166,281.431,284.697,287.103,289.12,292.856,296.121,297.624,300.5,302.906,307.031,311.155,314.891" y="226.03599999999994" svg_rhmargin="316.908" style="fill:#171615;font-family:NEAGBA+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">899 patients with drug-induced liver injury: the DILIN prospective study.</text>
  <text x="88.442,94.196,97.932,100.808,103.214,106.091,110.215,113.48,117.605,120.011,123.276,126.153,130.277,132.29399999999998,134.87,138.995,143.12,147.244,151.368,153.386,157.51,161.635,165.759,167.776,171.901,176.025,180.15" y="234.99300000000005" svg_rhmargin="184.274" style="fill:#171615;font-family:NEAGBA+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">Gastroenterol 2015;148:1340</text>
  <text x="184.309" y="234.99300000000005" svg_rhmargin="188.045" style="fill:#171615;font-family:NEAGKI+AdvOTbc475f09+20;font-size:7.47px;font-style:NORMAL;font-weight:normal;">–</text>
  <text x="188.051,192.176,196.302,198.319,200.865,204.131,208.256,212.381,216.506,220.631" y="234.99300000000005" svg_rhmargin="222.648" style="fill:#171615;font-family:NEAGBA+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">52. e1347.</text>
  <text x="72.058,74.464,78.589,82.713,85.119,88.442,92.955,97.08,99.78,105.145,108.41,111.175,116.539,120.664,123.54,127.665,129.68200000000002,132.433,138.657,142.393,146.129,150.254,153.519,156.39600000000002,159.134,164.499,166.516,169.281,173.406,177.53,180.407,184.531,187.796,190.539,195.904,201.269,203.286,206.016,209.281,211.687,214.463,218.198,220.216,222.233,224.95,230.315,232.332,235.209,239.334,242.07,246.195,248.601,251.367,255.103,258.368,262.493,264.899,268.164,270.925,272.942,274.959,278.695,281.961,284.838,287.591,289.997,293.733,295.75,297.768,301.892,304.769,308.034,310.777,312.794" y="243.95000000000005" svg_rhmargin="316.918" style="fill:#171615;font-family:NEAGBA+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">[32] Lo Re V3rd, Haynes K, Forde KA, et al. Risk of acute liver failure in</text>
  <text x="88.442,92.567,96.303,98.709,100.726,103.991,108.116,110.522,113.399,114.973,120.726,122.743,125.149,129.274,130.789,134.913,137.79,141.914,145.65,148.056,150.074,154.198,158.396,162.521,165.786,169.051,173.176,174.723,176.74,178.758,182.494,185.759,188.636,190.143,192.16,196.284,198.302,202.501,205.378,209.113,211.13,212.648,215.914,219.649,223.385,225.403,229.527,233.263,235.669,237.686,241.811,245.936,247.512,251.636,254.042,255.562,261.786" y="252.90700000000004" svg_rhmargin="265.522" style="fill:#171615;font-family:NEAGBA+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">patients with drug-induced liver injury: evaluation of Hy</text>
  <text x="265.55" y="252.90700000000004" svg_rhmargin="267.567" style="fill:#171615;font-family:NEAGKI+AdvOTbc475f09+20;font-size:7.47px;font-style:NORMAL;font-weight:normal;">’</text>
  <text x="267.592,270.469,271.957,273.974,277.71,283.46299999999997,285.052,288.788,292.913,297.038,298.544,302.28,303.816,307.941,311.206" y="252.90700000000004" svg_rhmargin="316.959" style="fill:#171615;font-family:NEAGBA+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">s law and a new</text>
  <text x="88.443,92.568,95.444,99.569,103.305,107.429,111.553,114.43,116.836,118.853,122.118,124.667,130.809,134.933,139.058,142.323,144.34,146.357,148.873,154.238,156.255,158.272,162.397,164.916,170.67,174.405,177.282,179.688,182.565,186.689,189.954,194.079,196.485,199.75,202.727,206.852,208.869,211.345,217.569,220.834,224.958,228.694,231.1,235.224,237.24099999999999,239.802,243.927,248.051,252.176,256.3,258.318,262.442,266.566,268.584,272.708,276.833,280.957" y="261.92100000000005" svg_rhmargin="285.081" style="fill:#171615;font-family:NEAGBA+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">prognostic model. Clin Gastroenterol Hepatol 2015;13:2360</text>
  <text x="285.11" y="261.92100000000005" svg_rhmargin="288.846" style="fill:#171615;font-family:NEAGKI+AdvOTbc475f09+20;font-size:7.47px;font-style:NORMAL;font-weight:normal;">–</text>
  <text x="288.852,292.976" y="261.92100000000005" svg_rhmargin="294.993" style="fill:#171615;font-family:NEAGBA+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">8.</text>
  <text x="72.059,74.465,78.589,82.714,85.12,88.442,94.584,98.32,100.726,104.851,110.604,114.34,118.464,120.481,122.512,127.876,133.241,135.258,137.307,141.432,145.168,147.185,150.062,152.103,155.839,157.856,159.869,165.234,168.499,172.235,176.359,180.484,182.501,186.626,189.50300000000001,191.558,196.459,200.972,202.989,204.993,208.258,210.66400000000002,212.703,216.439,218.456,220.47299999999998,222.51,226.246,229.512,232.388,236.513,242.655,244.676,248.412,250.43,254.165,258.29,260.307,264.432,267.697,269.732,273.468,279.61,281.627,285.752,289.876,292.282,295.242,298.978,303.102,305.979,308.385,311.65,314.526" y="270.879" svg_rhmargin="316.932" style="fill:#171615;font-family:NEAGBA+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">[33] Nathwani RA, Pais S, Reynolds TB, et al. Serum alanine aminotransfer-</text>
  <text x="88.443,92.179,95.056,98.321,100.802,102.819,106.944,109.476,112.352,116.477,119.742,121.759,125.024,127.43,131.166,133.183,135.722,141.864,145.989,148.865,152.131,154.148,157.41299999999998,159.929,164.053,166.071,168.947,172.213,175.948,178.825,182.09,184.967,186.984,189.52,195.744,199.009,203.134,206.87,209.276,213.4,215.417,217.977,222.102,226.226,230.351,234.475,236.492,240.617,244.741,246.759,250.883,255.008" y="279.836" svg_rhmargin="259.132" style="fill:#171615;font-family:NEAGBA+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">ase in skeletal muscle diseases. Hepatol 2005;41:380</text>
  <text x="259.201" y="279.836" svg_rhmargin="262.937" style="fill:#171615;font-family:NEAGKI+AdvOTbc475f09+20;font-size:7.47px;font-style:NORMAL;font-weight:normal;">–</text>
  <text x="262.943,267.068" y="279.836" svg_rhmargin="269.085" style="fill:#171615;font-family:NEAGBA+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">2.</text>
  <text x="72.059,74.465,78.589,82.714,85.12,88.442,93.807,97.932,102.056,104.933,108.198,112.323,114.122,119.487,122.364,124.381,126.141,133.613,137.349,139.755,143.879,145.897,150.021,152.898,154.712,158.837,163.349,165.36599999999999,167.184,172.085,176.21,179.475,181.243,183.649,186.525,190.261,194.386,197.262,199.668,203.793,206.752,212.894,216.63,219.036,221.053,225.178,229.303,231.072,233.089,237.214,239.008,243.133,245.15,249.274,255.416,259.152,262.029,266.153,269.418,272.295,274.155,278.279,281.544,283.95,287.215,290.481,292.886,294.904,299.028,303.153,304.936,308.672,312.797" y="288.793" svg_rhmargin="316.921" style="fill:#171615;font-family:NEAGBA+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">[34] Church RJ, Watkins PB. The transformation in biomarker detection and</text>
  <text x="88.443,94.585,98.321,102.445,106.181,109.917,113.182,119.324,122.589,126.714,129.12,131.639,135.764,138.17000000000002,140.711,144.835,147.712,151.836,155.572,157.978,159.995,164.12,168.244,172.369,175.634,178.899,183.024,185.551,187.569,189.586,193.322,196.587,199.464,201.991,204.008,208.132,210.15,214.274,217.151,220.887,222.904,225.46,229.973,231.99,235.726,238.991,241.86800000000002,244.394,246.8,250.924,253.33,255.845,259.97,264.095,268.219,272.344,274.361,278.485,282.61,284.627,288.752,292.876,297.0" y="297.75" svg_rhmargin="301.124" style="fill:#171615;font-family:NEAGBA+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">management of drug-induced liver injury. Liver Int 2017;37:1582</text>
  <text x="301.154" y="297.75" svg_rhmargin="304.89" style="fill:#171615;font-family:NEAGKI+AdvOTbc475f09+20;font-size:7.47px;font-style:NORMAL;font-weight:normal;">–</text>
  <text x="304.896,309.021,313.146" y="297.75" svg_rhmargin="315.163" style="fill:#171615;font-family:NEAGBA+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">90.</text>
  <text x="72.06,74.466,78.59,82.715,85.12100000000001,88.443,94.667,98.403,102.139,105.875,108.752,112.876,114.893,120.642,124.767,130.991,133.008,138.726,144.091,148.215,151.481,155.605,158.87,162.606,168.374,174.128,179.492,181.509,187.252,191.376,195.501,199.625,202.031,205.767,209.891,213.62699999999998,219.338,224.703,227.579,229.596,235.381,238.647,241.053,246.777,250.513,252.53,254.547,260.269,266.022,269.288,273.024,275.429,279.554,285.326,289.062,293.186,297.311,303.013,305.03,307.048,310.784,314.049" y="306.707" svg_rhmargin="316.926" style="fill:#171615;font-family:NEAGBA+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">[35] Hayashi PH, Rockey DC, Fontana RJ, et al. Death and liver</text>
  <text x="88.444,90.85,93.726,97.462,101.587,104.463,108.588,110.605,114.341,118.466,120.872,124.607,127.013,129.031,133.155,137.28,140.824,146.578,148.595,151.001,155.125,157.143,161.268,164.803,168.928,172.4,176.136,179.401,183.137,186.014,188.89100000000002,192.411,196.535,198.941,202.389,206.513,210.638,213.514,216.78,219.186,222.684,226.808,229.214,232.718,236.842,239.719,243.843,247.579,249.985,252.002,256.127,260.324,264.45,267.715,270.98,275.105,278.579,280.597,282.614,286.35,289.615,292.492,295.983,298.0,302.125,304.142,308.266,311.143,314.879" y="315.664" svg_rhmargin="316.896" style="fill:#171615;font-family:NEAGBA+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">transplantation within 2 years of onset of drug-induced liver injury.</text>
  <text x="88.444,94.669,97.935,102.06,105.796,108.203,112.328,114.345,116.849,120.974,125.099,129.224,133.349,135.368,139.493,143.618,145.708,149.833,153.958,158.083" y="324.678" svg_rhmargin="162.207" style="fill:#171615;font-family:NEAGBA+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">Hepatol 2017;66:1275</text>
  <text x="162.201" y="324.678" svg_rhmargin="165.937" style="fill:#171615;font-family:NEAGKI+AdvOTbc475f09+20;font-size:7.47px;font-style:NORMAL;font-weight:normal;">–</text>
  <text x="165.943,170.068,174.193" y="324.678" svg_rhmargin="176.21" style="fill:#171615;font-family:NEAGBA+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">85.</text>
  <text x="72.06,74.466,78.59,82.715,85.12100000000001,88.443,93.345,96.61,99.487,102.752,106.876,111.001,114.266,116.391,121.755,123.77199999999999,125.914,131.668,135.403,139.528,143.264,147.389,149.554,155.307,157.32399999999998,159.474,165.227,167.245,170.98,174.716,178.841,182.965,185.842,187.859,190.73600000000002,192.863,196.599,200.723,204.848,206.979,213.121,216.857,220.982,224.718,228.521,231.786,237.928,241.193,245.317,247.723,249.836,253.96,256.366,258.509,262.633,265.51,269.634,273.37,275.776,277.794,281.918,286.116,290.241,293.506,296.771,300.896,303.01,305.027,307.045,310.781,314.046" y="333.636" svg_rhmargin="316.923" style="fill:#171615;font-family:NEAGBA+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">[36] Teschke R, Danan G. Diagnosis and management of drug-induced liver</text>
  <text x="88.444,90.461,94.586,96.603,100.728,103.604,107.34,112.026,114.432,120.186,122.592,127.105,129.599,132.005,136.686,138.703,142.828,147.514,151.638,155.374,157.78,159.872,163.137,167.262,169.668,172.54500000000002,177.219,182.973,184.99,187.396,191.521,196.267,200.392,203.268,206.533,208.939,212.205,216.329,218.346,221.223,223.629,225.745,229.869,233.605,238.274,240.291,242.308,246.044,249.31,252.187,256.925,261.049,263.067,265.943,269.208,272.944,275.821,279.086,281.103,285.836,291.589,294.466,298.591,302.327,307.038,310.774,314.51" y="342.593" svg_rhmargin="316.916" style="fill:#171615;font-family:NEAGBA+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">injury (DILI) in patients with pre-existing liver disease. Drug Saf</text>
  <text x="88.444,92.569,96.694,100.819,104.945,106.963,111.088,115.213,117.231,121.356,125.482" y="351.55" svg_rhmargin="129.606" style="fill:#171615;font-family:NEAGBA+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">2016;39:729</text>
  <text x="129.659" y="351.55" svg_rhmargin="133.395" style="fill:#171615;font-family:NEAGKI+AdvOTbc475f09+20;font-size:7.47px;font-style:NORMAL;font-weight:normal;">–</text>
  <text svg_rhmargin="143.668" x="133.401,137.526,141.651,143.668" y="37.75699999999995" style="fill:#171615;font-family:NEAGBA+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">44. </text>
  <text x="332.052,334.457,338.582,342.706,345.112,348.435,353.8,357.924,361.189,365.314,369.438,373.563,376.836,379.713,381.73,385.0,389.124,392.001,396.125,398.531,400.548,404.284,408.02,411.303,415.428,417.445,420.714,424.45,427.715,430.98,433.386,435.79200000000003,439.081,443.594,448.107,450.124,453.367,456.632,459.038,462.267,466.003,468.02,470.037,473.321,478.686,481.951,483.969,485.986,489.722,493.846,495.864,497.881,499.899,502.305,506.041,509.375,513.5,515.906,519.126,521.532,525.656,528.9209999999999,532.221,537.586,541.71,545.835,548.711,551.588,554.853,556.87,560.169,565.533,568.799,570.816,574.552" y="37.75699999999995" svg_rhmargin="576.958" style="fill:#171615;font-family:NEAGBA+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">[37] Rochon J, Protiva P, Seeff LB, et al. Reliability of the Roussel Uclaf</text>
  <text x="348.436,351.701,355.437,359.561,362.438,366.174,368.191,370.208,372.698,376.43399999999997,378.084,381.82,384.696,387.573,390.838,393.786,396.663,402.805,406.07,410.195,412.601,414.308,420.45,423.715,426.121,430.246,434.37,438.495,440.215,442.621,446.746,449.623,451.327,455.063,457.939,460.816,464.081,466.958,469.834,471.852,475.976,479.712,481.485,484.75,488.486,492.611,495.487,499.223,501.241,503.258,505.664,509.4,511.133,513.151,517.276,518.957,523.081,525.958,530.083,533.818,536.224,538.242,542.366,546.564,550.688,553.954,557.219,561.344,563.06,565.078,567.095,570.831,574.096" y="46.714000000000055" svg_rhmargin="576.973" style="fill:#171615;font-family:NEAGBA+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">causality assessment method for assessing causality in drug-induced liver</text>
  <text x="348.436,350.453,354.577,356.595,360.719,363.596,367.332,369.349,371.905,378.129,381.394,385.518,389.254,391.66,395.784,397.801,400.306,404.431,408.555,412.68,416.804,418.821,422.946,427.07,429.16,433.285,437.409,441.533" y="55.67100000000005" svg_rhmargin="445.657" style="fill:#171615;font-family:NEAGBA+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">injury. Hepatol 2008;48:1175</text>
  <text x="445.663" y="55.67100000000005" svg_rhmargin="449.399" style="fill:#171615;font-family:NEAGKI+AdvOTbc475f09+20;font-size:7.47px;font-style:NORMAL;font-weight:normal;">–</text>
  <text x="449.405,453.53,457.654" y="55.67100000000005" svg_rhmargin="459.671" style="fill:#171615;font-family:NEAGBA+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">83.</text>
  <text x="332.052,334.457,338.582,342.706,345.112,348.435,353.8,357.924,361.189,365.314,368.579,372.315,375.419,381.172,386.537,388.554,391.632,395.367,398.633,401.898,404.304,406.71,409.828,414.341,418.854,420.871,423.944,429.309,433.433,436.698,440.823,444.947,449.072,452.175,455.051,457.068,460.168,463.433,465.839,468.898,472.634,474.651,476.668,479.726,485.09,488.826,492.951,495.827,499.563,501.664,503.681,506.087,509.823,512.888,516.624,519.501,522.378,525.643,528.519,531.396,537.538,540.803,544.928,547.334,550.472,552.49,556.615,559.657,563.781,566.658,570.782,574.518" y="64.62800000000004" svg_rhmargin="576.924" style="fill:#171615;font-family:NEAGBA+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">[38] Rockey DC, Seeff LB, Rochon J, et al. Causality assessment in drug-</text>
  <text x="348.436,350.453,354.577,358.702,362.826,366.091,369.357,373.482,379.444,381.462,383.479,387.215,390.48,393.357,399.286,401.303,405.428,407.445,411.569,414.446,418.182,424.116,428.24,431.117,433.134,437.259,440.995,446.962,450.698,456.6,459.476,461.882,464.759,468.883,472.148,474.554,478.679,481.555,484.821,488.946,494.921,498.186,502.311,506.435,509.7,512.577,514.983,520.885,525.009,529.134,531.151,535.275,537.293,541.417,545.542,551.497,555.621,558.498,562.622,565.888,569.153,572.029,574.906" y="73.58600000000001" svg_rhmargin="576.923" style="fill:#171615;font-family:NEAGBA+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">induced liver injury using a structured expert opinion process:</text>
  <text x="348.436,351.701,355.825,361.967,366.091,369.827,372.704,374.721,377.687,381.811,385.936,388.231,390.637,394.762,397.075,399.481,403.605,406.87,409.15,414.515,418.639,422.764,425.64,428.594,431.859,433.876,436.282,441.647,444.912,446.93,450.665,453.071,455.407,458.672,462.408,466.533,469.409,473.145,475.163,477.18,479.586,483.322,485.679,489.415,492.292,495.168,498.433,501.31,504.187,510.329,513.594,517.718,520.1239999999999,522.47,528.611,531.877,534.283,538.407,542.531,546.732,548.749,551.04,557.265,560.53,564.655,568.391,570.797,574.921" y="82.543" svg_rhmargin="576.938" style="fill:#171615;font-family:NEAGBA+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">comparison to the Roussel-Uclaf causality assessment method. Hepatol</text>
  <text x="348.436,352.561,356.686,360.811,364.936,366.955,371.08,375.205,377.295,381.419,385.544,389.67" y="91.55700000000002" svg_rhmargin="393.794" style="fill:#171615;font-family:NEAGBA+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">2010;51:2117</text>
  <text x="393.789" y="91.55700000000002" svg_rhmargin="397.525" style="fill:#171615;font-family:NEAGKI+AdvOTbc475f09+20;font-size:7.47px;font-style:NORMAL;font-weight:normal;">–</text>
  <text x="397.531,401.656,405.78" y="91.55700000000002" svg_rhmargin="407.797" style="fill:#171615;font-family:NEAGBA+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">26.</text>
  <text x="332.052,334.457,338.582,342.706,345.112,348.435,353.336,357.072,361.197,363.287,367.8,374.024,376.041,378.14,382.653,386.777,392.53,394.637,399.15,404.903,408.639,410.656,412.777,418.531,422.267,426.392,428.48,433.845,439.21,441.227,443.333,446.598,449.004,451.1,454.836,456.853,458.87,460.964,464.7,468.436,471.312,473.718,476.983,483.125,486.861,489.267,491.284,494.549,496.734,499.611,502.876,506.612,508.629,511.895,517.648,519.75,523.486,527.611,531.736,533.809,539.952,543.217,545.623,549.359,551.765,555.501,559.625,563.361,565.379,569.115,571.991,574.115" y="100.51400000000001" svg_rhmargin="576.992" style="fill:#171615;font-family:NEAGBA+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">[39] Tan EH, Low EXS, Dan YY, et al. Systematic review and meta-analysis</text>
  <text x="348.436,352.56,354.966,357.166,360.902,362.919,366.655,370.779,373.656,375.673,378.079,382.204,388.346,391.223,393.446,397.57,400.447,403.712,407.837,410.056,412.461,416.586,418.73,420.747,424.871,428.137,432.261,434.667,436.684,439.09,442.82599999999996,445.09,449.214,452.091,456.215,459.951,462.357,464.375,468.499,472.624,476.748,480.013,483.278,487.403,489.59,491.607,493.624,497.36,500.701,503.57800000000003,505.747,507.764,511.889,513.906,518.03,520.907,524.643,526.835,529.241,534.994,537.4,541.913,544.319,546.7249999999999,548.944,550.961,555.086,557.277,561.401,564.667,568.402,570.42,572.826" y="109.471" svg_rhmargin="576.95" style="fill:#171615;font-family:NEAGBA+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">of algorithms used to identify drug-induced liver injury (DILI) in health</text>
  <text x="348.436,351.312,354.577,357.843,361.967,364.844,368.969,371.508,375.632,379.368,381.774,385.51,389.634,393.37,396.247,399.512,402.389,404.406,406.938,411.451,413.468,417.204,420.469,423.346,425.872,428.278,432.402,434.808,437.323,441.448,445.572,449.696,453.821" y="118.42899999999997" svg_rhmargin="455.838" style="fill:#171615;font-family:NEAGBA+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">record databases. Liver Int 2017.</text>
  <text x="332.052,334.457,338.582,342.706,345.112,348.435,354.659,358.783,361.66,365.784,369.977,373.71299999999997,376.95,382.316,385.192,387.209,390.5,394.235,396.641,400.377,403.254,407.378,410.644,414.38,417.71,422.223,425.488,431.242,433.259,436.136,439.422,443.546,445.563,448.833,454.587,457.852,461.588,464.46500000000003,467.768,470.644,472.661,475.931,479.197,481.603,484.889,488.624,490.642,492.659,495.943,503.415,505.432,508.697,511.646,515.77,521.135,527.277,532.642,535.519,538.8,542.536,545.4129999999999,548.721,552.845,556.97,559.376,562.641,566.765,569.171,571.189,574.925" y="127.38599999999997" svg_rhmargin="576.942" style="fill:#171615;font-family:NEAGBA+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">[40] Hornby RJ, Starkey Lewis P, Dear J, et al. MicroRNAs as potential</text>
  <text x="348.436,351.701,353.718,356.595,359.86,363.984,366.002,369.738,372.144,374.161,378.285,382.021,385.68,389.805,391.822,395.947,402.088,405.824,408.701,412.825,416.179,419.055,421.932,425.533,429.657,432.063,435.623,439.748,442.624,446.749,450.485,452.891,454.908,459.032,463.23,467.354,470.62,473.885,478.01,481.597,483.615,485.632,489.368,492.633,495.51,499.114,501.131,505.256,507.273,511.472,514.349,518.085,520.1020000000001,523.66,527.785,531.05,534.786,538.4,541.665,545.79,548.666,551.543,554.808,558.933,561.3389999999999,564.987,568.723,572.847" y="136.34299999999996" svg_rhmargin="576.971" style="fill:#171615;font-family:NEAGBA+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">circulating biomarkers of drug-induced liver injury: key current and</text>
  <text x="348.436,350.842,354.966,357.372,361.496,364.373,367.638,371.281,373.299,376.175,379.052,383.177,386.442,389.319,392.88,395.286,399.41,402.28700000000003,405.862,408.268,411.145,414.881,419.005,421.882,423.899,427.635,430.125,432.142,436.267,440.392,443.957,446.363,450.488,454.049,458.174,462.298,468.44,472.176,476.3,479.177,481.194,484.831,489.344,493.468,497.593,500.858,503.735,506.141,509.717,515.082,518.347,522.083,525.647,531.013,533.03,535.047,539.172,542.768,546.893,551.017,554.753,557.63,563.771,567.507,570.772,574.967" y="145.35699999999997" svg_rhmargin="576.984" style="fill:#171615;font-family:NEAGBA+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">future issues for translation to humans. Expert Rev Clin Pharmacol</text>
  <text x="348.436,352.56,356.685,360.809,364.933,366.951,371.075,373.093,377.29,381.415" y="154.31399999999996" svg_rhmargin="385.539" style="fill:#171615;font-family:NEAGBA+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">2014;7:349</text>
  <text x="385.513" y="154.31399999999996" svg_rhmargin="389.249" style="fill:#171615;font-family:NEAGKI+AdvOTbc475f09+20;font-size:7.47px;font-style:NORMAL;font-weight:normal;">–</text>
  <text x="389.255,393.379,397.504" y="154.31399999999996" svg_rhmargin="399.521" style="fill:#171615;font-family:NEAGBA+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">62.</text>
  <text x="332.052,334.458,338.583,342.707,345.113,348.436,353.8,357.925,362.05,365.669,371.034,375.547,377.564,381.146,386.51,388.528,394.67,398.266,402.002,408.226,410.243,413.799,418.312,421.577,424.842,428.425,432.938,439.162,441.179,444.808,448.074,450.48,454.049,457.785,459.802,461.819,465.386,470.751,472.769,475.645,478.91,483.035,485.052,488.788,491.194,493.211,497.336,501.072,504.728,508.854,510.871,514.607,517.484,523.625,527.361,530.976,534.712,538.837,542.962,546.509,549.775,553.899,558.023,560.9,565.025,571.166,574.902" y="163.27099999999996" svg_rhmargin="576.919" style="fill:#171615;font-family:NEAGBA+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">[41] Cho YE, Kim SH, Lee BH, et al. Circulating plasma and exosomal</text>
  <text x="348.436,354.578,356.596,359.861,362.737,366.862,372.227,378.368,383.733,386.61,388.231,391.967,394.844,396.395,398.412,402.537,406.661,408.678,411.944,415.68,418.085,422.21,425.087,427.964,429.558,433.682,436.088,437.665,441.789,444.666,448.79,452.526,454.932,456.949,461.074,465.198,469.323,472.588,475.853,479.978,481.541,485.666,488.542,492.278,496.014,500.139,501.722,503.74,507.864,509.882,514.006,516.883,520.619,522.187,524.204,528.329,529.84,532.717,536.841,540.966,544.296,548.421,550.827,552.346,558.488,562.613,566.737,570.002,572.02,574.896" y="172.22900000000004" svg_rhmargin="576.913" style="fill:#171615;font-family:NEAGBA+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">microRNAs as indicators of drug-induced organ injury in rodent models.</text>
  <text x="348.436,352.949,354.967,359.091,365.233,369.357,371.374,373.946,378.847,382.972,386.237,389.11400000000003,391.576,393.982,397.718,400.983,405.182,409.306,411.323,413.729,416.236,420.361,424.485,428.609,432.734,434.751,438.876,443.0,445.017,449.142,453.266" y="181.18600000000004" svg_rhmargin="457.39" style="fill:#171615;font-family:NEAGBA+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">Biomol Ther (Seoul) 2017;25:367</text>
  <text x="457.456" y="181.18600000000004" svg_rhmargin="461.192" style="fill:#171615;font-family:NEAGKI+AdvOTbc475f09+20;font-size:7.47px;font-style:NORMAL;font-weight:normal;">–</text>
  <text x="461.198,465.323,469.448" y="181.18600000000004" svg_rhmargin="471.465" style="fill:#171615;font-family:NEAGBA+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">73.</text>
  <text x="332.052,334.458,338.583,342.707,345.113,348.436,353.8,357.925,362.049,364.067,367.332,370.208,372.698,378.451,380.469,384.205,387.46999999999997,389.818,397.29,399.307,401.609,409.081,412.346,416.471,418.488,422.613,426.349,428.754,434.205,437.941,439.958,441.976,445.241,447.584,449.99,452.007,454.33,458.066,460.472,463.737,467.862,471.986,475.251,479.376,482.253,484.602,489.966,491.983,494.296,497.561,499.967,502.346,506.082,508.099,510.116,512.436,516.949,518.967,523.091,529.233,532.969,535.846,539.97,543.235,546.112,548.9889999999999,551.381,553.398,557.523,559.828,565.581,567.987,572.5,574.906" y="190.14300000000003" svg_rhmargin="576.923" style="fill:#171615;font-family:NEAGBA+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">[42] Robles-Diaz M, Medina-Caliz I, Stephens C, et al. Biomarkers in DILI:</text>
  <text x="348.436,352.561,356.685,359.95,362.495,368.637,372.762,375.638,378.90299999999996,381.373,384.249,386.655,389.921,394.046,396.566,398.972,403.096,405.973,411.726,415.462,418.339,422.463,424.48,427.064,431.189,434.065,438.19,442.314,444.72,447.246,451.37,455.494,459.23,462.107,468.249,471.985,475.25,479.374,481.391,483.922,488.047,492.171,496.296,500.42,502.437,506.562,508.579,512.704,516.828,520.953" y="199.10000000000002" svg_rhmargin="522.97" style="fill:#171615;font-family:NEAGBA+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">one more step forward. Front Pharmacol 2016;7:267.</text>
  <text x="332.052,334.458,338.583,342.707,345.113,348.436,353.337,356.602,359.479,362.744,366.869,370.993,374.258,376.893,382.258,384.275,386.871,390.606,393.872,397.996,402.12,404.138,407.403,410.668,413.287,416.164,418.181,420.77,425.283,427.3,430.566,434.69,438.814,442.939,445.345,447.75100000000003,450.418,455.783,457.8,460.395,463.66,466.06600000000003,468.616,472.352,474.369,476.386,478.99,484.743,487.62,491.744,495.48,498.093,500.111,504.235,508.36,512.484,515.749,519.015,523.14,525.758,527.775,529.793,533.529,536.794,539.6709999999999,542.311,544.328,548.453,550.47,554.595,557.471,561.207,563.224,565.837,569.102,572.838" y="208.11400000000003" svg_rhmargin="576.962" style="fill:#171615;font-family:NEAGBA+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">[43] Teschke R, Schulze J, Eickhoff A, et al. Drug induced liver injury: can</text>
  <text x="348.436,352.561,354.578,358.703,364.844,368.58,371.457,375.581,378.935,381.811,384.688,389.139,392.875,395.752,398.628,400.646,403.522,405.928,410.398,415.763,421.127,426.492,431.94,439.412,443.845,445.863,449.988,454.446,457.711,461.447,465.572,468.448,472.184,474.202,476.219,478.625,482.361,486.872,490.608,493.485,496.362,499.627,502.503,505.38,511.522,514.787,518.911,521.317,524.582,529.105,531.511,535.636,538.0419999999999,542.541,545.418,549.855,557.326,561.451,563.4680000000001,567.939,571.675,574.94" y="217.07100000000003" svg_rhmargin="576.957" style="fill:#171615;font-family:NEAGBA+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">biomarkers assist RUCAM in causality assessment? Int J Mol Sci</text>
  <text x="348.436,352.561,356.685,360.81,364.934,366.951,371.076,375.2,377.687,381.811,383.829,386.235" y="226.029" svg_rhmargin="388.252" style="fill:#171615;font-family:NEAGBA+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">2017;18(4.):</text>
  <text x="332.052,334.458,338.583,342.707,345.113,348.436,352.172,356.297,360.114,363.85,365.867,369.694,375.059,378.795,382.92,386.758,394.23,396.247,400.081,404.594,406.612,410.737,414.537,422.009,424.026,427.859,431.125,433.531,437.327,441.063,443.08,445.097,448.948,454.702,458.826,462.562,464.579,466.985,473.127,477.252,481.376,484.64099999999996,488.517,491.782,493.799,497.065,500.33,502.736,505.612,509.737,513.002,517.126,520.392,526.533,528.551,531.816,535.552,537.5690000000001,541.464,545.199,549.324,553.06,555.077,558.813,561.69,563.707,566.584,570.432,574.556" y="234.986" svg_rhmargin="576.962" style="fill:#171615;font-family:NEAGBA+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">[44] Su S, Cao W, Liu W, et al. Dual-mode electrochemical analysis of</text>
  <text x="348.436,354.578,356.596,359.861,362.737,366.862,372.227,378.368,383.733,386.247,390.372,394.497,399.4,403.524,406.401,408.418,412.543,416.279,421.169,424.905,429.029,431.047,435.172,440.047,444.171,447.907,452.031,456.156,460.341,464.077,466.953,469.359,471.376,474.642,476.659,479.924,482.33,486.455,489.72,492.985,497.109,499.986,503.722,506.128,509.393,513.518,518.503,525.974,530.099,533.835,537.96,542.879,547.003,550.739,554.863,558.988,561.865,565.989,569.254,572.519,574.925" y="243.94299999999998" svg_rhmargin="576.942" style="fill:#171615;font-family:NEAGBA+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">microRNA-21 using gold nanoparticle-decorated MoS2 nanosheet.</text>
  <text x="348.436,352.949,354.967,359.091,361.968,365.233,369.357,372.23400000000004,374.796,379.309,381.327,385.451,388.716,390.733,393.999,397.264,399.67,402.546,406.671,410.796,413.344,417.469,421.593,425.718,429.842,431.86,435.984,440.109,442.126,446.25,450.375" y="252.89999999999998" svg_rhmargin="454.499" style="fill:#171615;font-family:NEAGBA+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">Biosens Bioelectron 2017;94:552</text>
  <text x="454.565" y="252.89999999999998" svg_rhmargin="458.301" style="fill:#171615;font-family:NEAGKI+AdvOTbc475f09+20;font-size:7.47px;font-style:NORMAL;font-weight:normal;">–</text>
  <text x="458.307,462.431" y="252.89999999999998" svg_rhmargin="464.448" style="fill:#171615;font-family:NEAGBA+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">9.</text>
  <text x="332.052,334.458,338.583,342.707,345.113,348.436,352.949,354.966,357.372,362.737,366.861,370.986,373.719,379.861,384.373,386.39,389.138,393.263,396.999,402.752,406.017,409.753,412.494,418.636,424.001,426.018,428.707,433.22,435.238,437.644,441.38,445.504,448.769,450.872,454.997,459.122,461.813,465.549,473.021,475.038,477.743,481.008,483.414,486.133,489.869,491.887,493.904,496.621,501.986,504.003,506.88,510.145,514.269,516.287,520.022,522.428,524.446,528.57,532.306,535.056,541.198,543.216,548.581,554.722,560.087,562.493,566.617,570.742,574.965" y="261.914" svg_rhmargin="576.982" style="fill:#171615;font-family:NEAGBA+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">[45] El-Abd NE, Fawzy NA, El-Sheikh SM, et al. Circulating miRNA-122,</text>
  <text x="348.436,354.578,356.596,361.96,368.102,373.467,375.873,379.997,384.122,388.345,392.081,394.098,398.039,401.775,405.899,410.024,413.968,420.11,422.128,427.574,433.716,439.08,441.486,445.611,449.736,453.707,457.443,460.32,464.251,468.376,470.393,474.518,480.659,484.395,487.272,491.396,494.75,497.626,500.503,504.444,506.85,510.974,513.851,517.823,521.088,524.824,527.7,529.718,533.454,537.437,541.561,544.827,547.232,550.498,553.763,556.169,558.186,562.311,566.436,570.43,574.554" y="270.871" svg_rhmargin="576.96" style="fill:#171615;font-family:NEAGBA+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">miRNA-199a, and miRNA-16 as biomarkers for early detection of</text>
  <text x="348.436,352.561,355.826,359.95,363.686,366.092,370.217,373.482,376.747,378.764,380.782,385.0,387.018,390.754,393.63100000000003,395.828,399.093,402.829,405.705,408.971,410.988,415.112,419.237,425.476,429.212,431.429,433.446,437.571,439.762,444.276,448.011,451.747,455.872,458.278,460.295,464.031,468.156,470.431,474.556,478.292,480.698,482.715,485.98,490.105,492.51,495.387,497.641,503.395,505.412,507.818,511.943,514.194,517.46,521.584,524.461,528.585,532.71,534.727,537.992,540.271,546.495,549.76,553.885,557.621,560.027,562.044,564.45,566.467,569.3439999999999,571.62" y="279.82899999999995" svg_rhmargin="576.985" style="fill:#171615;font-family:NEAGBA+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">hepatocellular carcinoma in Egyptian patients with chronic Hepatitis C</text>
  <text x="348.436,352.172,354.19,357.066,361.191,364.068,366.577,368.595,372.719,375.125,378.39,381.655,384.151,386.168,390.293,394.417,396.43399999999997,398.946,406.418,410.543,412.56,415.046,420.8,422.817,426.553,430.289,434.414,436.929,441.83,445.955,449.22,452.09700000000004,454.616,458.74,462.865,466.989,471.114,473.131,477.255,481.38,483.47,487.594,491.718" y="288.786" svg_rhmargin="495.842" style="fill:#171615;font-family:NEAGBA+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">virus infection. Mol Diagn Ther 2015;19:213</text>
  <text x="495.837" y="288.786" svg_rhmargin="499.573" style="fill:#171615;font-family:NEAGKI+AdvOTbc475f09+20;font-size:7.47px;font-style:NORMAL;font-weight:normal;">–</text>
  <text x="499.579,503.704,507.829" y="288.786" svg_rhmargin="509.846" style="fill:#171615;font-family:NEAGBA+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">20.</text>
  <text x="332.052,334.458,338.583,342.707,345.113,348.436,352.56,356.296,359.173,363.298,365.726,371.95,377.315,379.332,381.826,384.702,388.827,391.236,398.708,400.725,403.141,408.506,412.63,416.755,418.772,421.225,427.45,430.327,432.344,434.774,438.04,440.446,442.881,446.617,448.635,450.652,453.086,457.987,460.005,466.146,469.411,471.817,475.083,479.207,483.331,486.304,489.181,492.44599999999997,494.865,498.13,502.254,505.99,510.115,513.851,517.116,519.9929999999999,522.416,524.433,528.558,531.033,533.439,537.563,540.828,543.221,546.486,550.611,554.735,557.677,560.942,563.818,566.695,568.713,572.837" y="297.743" svg_rhmargin="576.961" style="fill:#171615;font-family:NEAGBA+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">[46] Park HK, Jo W, Choi HJ, et al. Time-course changes in the expression</text>
  <text x="348.436,350.454,353.719,357.455,360.72,362.737,365.61400000000003,369.695,373.82,376.226,380.296,386.438,388.455,393.82,396.226,400.35,404.475,408.599,410.616,414.706,417.112,421.236,425.361,429.485,431.502,435.567,439.303,443.428,447.553,451.611,454.017,458.141,462.266,466.35,470.086,472.963,477.008,483.15,486.886,489.762,493.887,497.152,500.029,502.906,506.996,511.121,513.5269999999999,517.54,519.558,521.575,525.311,528.576,531.453,535.568,538.833,542.098,544.115,546.1320000000001,550.194,554.318,558.054,564.196,567.932,571.668,574.933" y="306.7" svg_rhmargin="576.95" style="fill:#171615;font-family:NEAGBA+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">levels of miR-122, -155, and -21 as markers of liver cell damage,</text>
  <text x="348.436,350.454" y="315.657" svg_rhmargin="354.578" style="fill:#171615;font-family:NEAGBA+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">in</text>
  <text x="354.616" y="315.657" svg_rhmargin="358.74" style="fill:#171615;font-family:NEAGBC+AdvOTbc475f09+fb;font-size:7.47px;font-style:NORMAL;font-weight:normal;">ﬂ</text>
  <text x="358.754,362.49,368.632,374.774,378.51,380.916,382.933,387.057,391.182,393.199,394.751,398.487,402.611,406.736,408.3,411.176,414.441,418.177,421.443,425.567,428.832,431.709,435.445,437.851,439.868,443.992,448.117,449.682,451.7,455.825,457.336,461.071,464.337,467.602,470.008,473.744,479.885,481.995,486.12,490.244,494.369,498.493,501.758,505.883,508.289,510.306,514.43,518.555,522.679,525.945,529.21,533.335,534.885,536.903,538.92,542.656,545.997,548.8739999999999,550.362,552.379,556.504,558.521,562.645,565.522,569.258,570.826,572.844" y="315.657" svg_rhmargin="576.968" style="fill:#171615;font-family:NEAGBA+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">ammation, and regeneration in acetaminophen-induced liver injury in</text>
  <text x="348.436,351.313,355.049,357.455,360.332,362.349,364.876,367.753,370.262,375.627,378.892,381.298,383.811,387.547,390.812,392.829,395.319,399.443,403.568,407.692,411.817,413.834,417.958,422.083,424.173,428.298" y="324.671" svg_rhmargin="432.422" style="fill:#171615;font-family:NEAGBA+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">rats. J Vet Sci 2016;17:45</text>
  <text x="432.455" y="324.671" svg_rhmargin="436.191" style="fill:#171615;font-family:NEAGKI+AdvOTbc475f09+20;font-size:7.47px;font-style:NORMAL;font-weight:normal;">–</text>
  <text x="436.14,440.265,444.39" y="324.671" svg_rhmargin="446.407" style="fill:#171615;font-family:NEAGBA+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">51.</text>
  <text x="332.052,334.458,338.583,342.707,345.113,348.436,354.189,357.454,361.19,364.067,365.896,368.772,376.244,378.261,380.124,385.49,387.507,391.243,394.12,398.244,401.509,403.311,406.187,408.593,410.61,412.438,416.562,419.439,423.175,427.299,430.564,432.582,435.459,437.324,441.837,443.854,445.657,448.922,451.32800000000003,453.14,456.876,458.894,460.911,462.721,468.085,470.103,472.979,477.104,478.934,481.81,484.216,487.093,490.829,493.235" y="333.629" svg_rhmargin="495.252" style="fill:#171615;font-family:NEAGBA+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">[47] Dear JW, Clarke JI, Francis B, et al. Risk strati</text>
  <text x="495.327" y="333.629" svg_rhmargin="499.451" style="fill:#171615;font-family:NEAGBC+AdvOTbc475f09+fb;font-size:7.47px;font-style:NORMAL;font-weight:normal;">ﬁ</text>
  <text x="499.465,502.731,506.466,508.872,510.89,515.014,519.139,520.951,524.686,527.092,529.498,532.764,535.641,537.504,541.628,545.364,548.241,551.977,555.242,558.507,560.913,564.649,570.791,574.915" y="333.629" svg_rhmargin="576.932" style="fill:#171615;font-family:NEAGBA+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">cation after paracetamol</text>
  <text x="348.436,352.561,356.297,359.562,362.439,366.563,370.687,373.564,376.829,380.182,384.306,387.183,389.2,393.325,397.061,400.363,406.506,409.771,413.036,417.16,420.896,425.021,427.12,429.997,432.403,434.42,437.685,441.01,445.134,447.152,451.276,457.418,461.154,464.03,468.155,471.42,474.297,477.173,479.19,482.562,485.439,488.704,491.58,495.705,497.722,500.128,503.005,506.315,508.721,511.597,515.722,521.864,525.249,527.655,533.408,537.533,540.839,544.963,547.84,551.965,554.841,558.966,562.231,565.496,567.902,569.919,573.655" y="342.586" svg_rhmargin="576.92" style="fill:#171615;font-family:NEAGBA+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">overdose using mechanistic biomarkers: results from two prospective</text>
  <text x="348.435,351.7,355.824,359.949,364.073,366.95,369.356,371.903,374.78,377.186,381.31,385.435,387.452,390.717,393.594,395.611,398.15,402.663,406.399,410.524,413.789,417.054,419.46,421.959,427.712,431.448,434.325,436.812,439.688,443.813,447.078,451.202,453.608,456.873,459.75,463.874,465.891,468.387,474.611,477.877,482.001,485.737,488.143,492.267,494.284,496.845,500.97,505.095,509.219,513.344,515.361,519.485,521.503,525.627,529.752" y="351.559" svg_rhmargin="533.876" style="fill:#171615;font-family:NEAGBA+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">cohort studies. Lancet Gastroenterol Hepatol 2018;3:104</text>
  <text x="533.932" y="351.559" svg_rhmargin="537.668" style="fill:#171615;font-family:NEAGKI+AdvOTbc475f09+20;font-size:7.47px;font-style:NORMAL;font-weight:normal;">–</text>
  <text x="537.674,541.799,545.925" y="351.559" svg_rhmargin="547.942" style="fill:#171615;font-family:NEAGBA+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">13.</text>
  <text svg_rhmargin="180.416" x="71.887,76.119,77.53,81.762,84.416,88.481,90.8,93.43,97.495,98.906,101.058,103.691,110.242,114.307,118.866,120.277,124.342,125.752,129.985,134.05,136.629,138.533,142.933,147.333,151.732,156.132,158.037,160.665,165.065,169.464,171.616,176.016,180.415" y="9.870999999999981" style="fill:#171615;font-family:NEAFPK+AdvOT6e5d2ec0;font-size:7.97px;font-style:NORMAL;font-weight:normal;">Liu et al. Medicine (2018) 97:49 </text>
  <text x="542.723,549.944,554.503,559.317,561.31,565.869,567.861,572.508" y="9.870999999999981" svg_rhmargin="577.067" style="fill:#171615;font-family:NEAFPJ+AdvOT34fe1490.B;font-size:7.97px;font-style:NORMAL;font-weight:normal;">Medicine</text>
  <text x="322.243" y="739.625" svg_rhmargin="326.643" style="fill:#171615;font-family:NEAGIH+AdvOTf94803d4;font-size:7.97px;font-style:NORMAL;font-weight:normal;">8</text>
 </g>
</svg>
